A breakthrough for those with inoperable lung cancer.
Pharmac is funding a new immunotherapy medicine, called infensey for those with New Zealand's deadliest cancer.
It's the first medicine of its kind funded for lung cancer and will be available for anyone to access.
Lung Foundation CEO Philip Hope says this is a massive step forward in the fight against cancer.
He says the drug gives patients diagnosed with stage 3 non-small cell lung cancer a good option when undergoing treatment.
LISTEN ABOVE

Kevin Putt: Former Springbok previews the final Greatest Rivalry test between the All Blacks and Springboks
02:18

Leon Panetta: Former Defence Secretary and CIA Director on the US-Iran war
08:17

Graeme Edgeler: Constitutional law expert on an MSD review which found more than 30-thousand cases, where benefits and payments were wrongly suspended
04:04